- Home
- TCRX vs MHH Comparison
TCRX vs MHH Comparison
Compare TCRX & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TCRX | MHH |
|---|---|---|
| Founded | 2018 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.1M | 72.6M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | TCRX | MHH |
|---|---|---|
| Price | $0.98 | $6.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 580.7K | 22.3K |
| Earning Date | 05-08-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.28 | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $10,325,000.00 | ★ $191,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.81 | $9.07 |
| P/E Ratio | ★ N/A | $331.00 |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.88 | $5.51 |
| 52 Week High | $2.57 | $8.37 |
Technical Indicators
Market Signals| Indicator | TCRX | MHH |
|---|---|---|
| Relative Strength Index (RSI) | 40.60 | 46.38 |
| Support Level | $0.91 | $5.55 |
| Resistance Level | $1.16 | $6.73 |
| Average True Range (ATR) | 0.06 | 0.42 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 21.57 | 66.67 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. The IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.